| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001782372 |
| P356 | DOI | 10.1007/S12016-015-8501-Z |
| P698 | PubMed publication ID | 26194940 |
| P50 | author | Jonathan M. Spergel | Q37370578 |
| P2093 | author name string | Antonella Cianferoni | |
| P2860 | cites work | Future therapies for food allergies | Q24630319 |
| Myofibroblasts and mechano-regulation of connective tissue remodelling | Q28216468 | ||
| Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract1 | Q28243179 | ||
| Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment | Q28252340 | ||
| Eosinophilic esophagitis | Q28278849 | ||
| Common variants at 5q22 associate with pediatric eosinophilic esophagitis | Q28943383 | ||
| Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids | Q33596197 | ||
| TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells | Q33771736 | ||
| Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51. | Q33834088 | ||
| The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children | Q33968378 | ||
| An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. | Q53226482 | ||
| A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. | Q53588622 | ||
| Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. | Q53649810 | ||
| What is the optimal occlusion time for the atopy patch test in the diagnosis of food allergies in children with atopic dermatitis? | Q53847472 | ||
| IL-5 promotes eosinophil trafficking to the esophagus. | Q53978537 | ||
| Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study. | Q54351284 | ||
| Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. | Q54624920 | ||
| Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis. | Q55043164 | ||
| Eosinophilic gastrointestinal disease suggestive of pathogenesis-related class 10 (PR-10) protein allergy resolved after immunotherapy | Q57987954 | ||
| Escalating incidence of eosinophilic esophagitis: A 20-year prospective, population-based study in Olten County, Switzerland | Q58019861 | ||
| Distinctive Blood Eosinophilic Phenotypes and Cytokine Patterns in Eosinophilic Esophagitis, Inflammatory Bowel Disease and Airway Allergy | Q58848601 | ||
| Dichotomy of food and inhalant allergen sensitization in eosinophilic esophagitis | Q61863674 | ||
| Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial | Q61959735 | ||
| Mepolizumab does not alter levels of eosinophils, T cells, and mast cells in the duodenal mucosa in eosinophilic esophagitis | Q61959737 | ||
| Anti–TNF-α (infliximab) therapy for severe adult eosinophilic esophagitis | Q61959752 | ||
| Cytokine Expression in Healthy and Inflamed Mucosa: Probing the Role of Eosinophils in the Digestive Tract | Q61959780 | ||
| Eosinophilic esophagitis: Escalating epidemiology? | Q61959781 | ||
| Eosinophils Express Functional IL-13 in Eosinophilic Inflammatory Diseases | Q61959803 | ||
| Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response | Q61959815 | ||
| Combined skin prick and patch testing enhances identification of food allergy in infants with atopic dermatitis | Q70916285 | ||
| Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula | Q71737350 | ||
| Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys | Q74339887 | ||
| IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism | Q74599784 | ||
| The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis | Q77633190 | ||
| Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis | Q79158073 | ||
| Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice | Q79460200 | ||
| Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis | Q79964941 | ||
| Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? | Q80195700 | ||
| Association of eosinophilic inflammation with esophageal food impaction in adults | Q81810836 | ||
| Eosinophilic esophagitis after specific oral tolerance induction for egg protein | Q83082052 | ||
| Possible eosinophilic esophagitis induced by milk oral immunotherapy | Q83212042 | ||
| Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis | Q83809844 | ||
| Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet | Q84487828 | ||
| Identification of specific foods responsible for inflammation in children with eosinophilic esophagitis successfully treated with empiric elimination diet | Q84592868 | ||
| Elevated plasma cytokines in Japanese patients with eosinophilic esophagitis and gastroenteritis | Q84957850 | ||
| Eosinophilic esophagitis | Q87353013 | ||
| Resolution of acute IgE-mediated allergy with development of eosinophilic esophagitis triggered by the same food | Q87455687 | ||
| Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season. | Q47688898 | ||
| Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice | Q47733530 | ||
| Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases | Q47803571 | ||
| Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors | Q48473259 | ||
| Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial | Q48509747 | ||
| Omalizumab in the treatment of eosinophilic esophagitis and food allergy. | Q48619297 | ||
| Egg oral immunotherapy in nonanaphylactic children with egg allergy. | Q50702311 | ||
| Food allergy in children: results of a standardized protocol for oral desensitization. | Q50903608 | ||
| A pilot study of the usefulness and safety of a ready-to-use atopy patch test (Diallertest) versus a comparator (Finn Chamber) during cow's milk allergy in children. | Q51307547 | ||
| Oral specific desensitization in food-allergic children. | Q52676121 | ||
| 14 years of eosinophilic esophagitis: clinical features and prognosis. | Q37378395 | ||
| Epigenetic mechanisms of regulation of Foxp3 expression | Q37412329 | ||
| Demethylation of the human eotaxin-3 gene promoter leads to the elevated expression of eotaxin-3. | Q37517405 | ||
| Basophils and allergic inflammation | Q37520281 | ||
| Invariant natural killer T cells in children with eosinophilic esophagitis. | Q37588544 | ||
| Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. | Q37632813 | ||
| Prevalence of eosinophilic esophagitis in the United States | Q37634307 | ||
| Eosinophilic esophagitis: updated consensus recommendations for children and adults | Q37863307 | ||
| ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). | Q38097271 | ||
| The management of eosinophilic esophagitis | Q38190719 | ||
| Enterocyte expression of the eotaxin and interleukin-5 transgenes induces compartmentalized dysregulation of eosinophil trafficking. | Q38293807 | ||
| The enhancer and promoter landscape of human regulatory and conventional T-cell subpopulations | Q38308192 | ||
| A striking local esophageal cytokine expression profile in eosinophilic esophagitis. | Q38338212 | ||
| Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. | Q38959847 | ||
| Expression of toll-like receptors 2 and 3 on esophageal epithelial cell lines and on eosinophils during esophagitis | Q39465391 | ||
| Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis | Q39600165 | ||
| A case-control study of sociodemographic and geographic characteristics of 335 children with eosinophilic esophagitis | Q39867899 | ||
| IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. | Q40036792 | ||
| Histone methylation mediates plasticity of human FOXP3(+) regulatory T cells by modulating signature gene expressions | Q40145396 | ||
| Effect of Sch 55700, a humanized monoclonal antibody to human interleukin-5, on eosinophilic responses and bronchial hyperreactivity | Q40924236 | ||
| Molecular diagnosis of eosinophilic esophagitis by gene expression profiling. | Q41163839 | ||
| Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis | Q42463924 | ||
| Differences in skin-prick and patch-test reactivity are related to the heterogeneity of atopic eczema in infants | Q42662205 | ||
| Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis | Q42906332 | ||
| Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. | Q42935186 | ||
| Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis | Q42947882 | ||
| Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma study | Q43059225 | ||
| Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial | Q43067460 | ||
| Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis | Q43686203 | ||
| Eosinophilic esophagitis treated with immunotherapy to dust mites. | Q43952382 | ||
| Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate | Q43976603 | ||
| Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children | Q44471652 | ||
| Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism | Q44642524 | ||
| Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics | Q44863693 | ||
| Rapidly increasing incidence of eosinophilic esophagitis in a large cohort | Q45110756 | ||
| Eosionphilic oesophagitis in Cape Town, South Africa | Q45891528 | ||
| Esophageal remodeling in pediatric eosinophilic esophagitis | Q46304660 | ||
| Induction of thymic stromal lymphopoietin expression in keratinocytes is necessary for generating an atopic dermatitis upon application of the active vitamin D3 analogue MC903 on mouse skin | Q46466229 | ||
| Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is up-regulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription 6. | Q46638441 | ||
| Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). | Q46667239 | ||
| Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children | Q46780087 | ||
| Eosinophilic esophagitis: a 10-year experience in 381 children | Q46856158 | ||
| Involvement of mast cells in eosinophilic esophagitis. | Q33987527 | ||
| Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis | Q33996008 | ||
| Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease | Q34003041 | ||
| Global mapping of H3K4me1 and H3K4me3 reveals the chromatin state-based cell type-specific gene regulation in human Treg cells | Q34087849 | ||
| Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. | Q34132655 | ||
| Comparative analysis of FcεRI expression patterns in patients with eosinophilic and reflux esophagitis | Q34247074 | ||
| Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis | Q34331377 | ||
| Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells | Q34490922 | ||
| Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota | Q34518075 | ||
| Epigenetic regulation of the IL-13-induced human eotaxin-3 gene by CREB-binding protein-mediated histone 3 acetylation. | Q34787101 | ||
| Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling | Q34810184 | ||
| TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation | Q35686590 | ||
| Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis | Q35900865 | ||
| Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. | Q35923340 | ||
| The use of patch testing in the diagnosis of food allergy. | Q36013900 | ||
| Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis | Q36113580 | ||
| Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia | Q36153520 | ||
| Emergency care of esophageal foreign body impactions: timing, treatment modalities, and resource utilization. | Q36412936 | ||
| Effect of inhaled glucocorticoids in childhood on adult height | Q36454737 | ||
| Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. | Q36553408 | ||
| Eosinophilic esophagitis: pathogenesis, genetics, and therapy | Q36646469 | ||
| Esophageal epithelial and mesenchymal cross-talk leads to features of epithelial to mesenchymal transition in vitro. | Q36672891 | ||
| Food allergies and eosinophilic gastrointestinal illness | Q36808262 | ||
| Eosinophilic esophagitis in adults and children: evidence for a food allergy component in many patients | Q36815678 | ||
| Histopathologic features of eosinophilic esophagitis | Q37025134 | ||
| Nutritional management of eosinophilic esophagitis | Q37025165 | ||
| Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases. | Q37080521 | ||
| Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia | Q37124757 | ||
| A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy | Q37150568 | ||
| Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis | Q37150700 | ||
| Clinical efficacy and immune regulation with peanut oral immunotherapy | Q37301616 | ||
| Safety of a peanut oral immunotherapy protocol in children with peanut allergy | Q37316978 | ||
| Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy | Q37336159 | ||
| P433 | issue | 2 | |
| P921 | main subject | eosinophilic esophagitis | Q2057356 |
| P304 | page(s) | 159-174 | |
| P577 | publication date | 2015-07-22 | |
| P1433 | published in | Clinical Reviews in Allergy & Immunology | Q1932354 |
| P1476 | title | Eosinophilic Esophagitis: A Comprehensive Review | |
| P478 | volume | 50 |
| Q59136932 | A Distinct Esophageal mRNA Pattern Identifies Eosinophilic Esophagitis Patients With Food Impactions |
| Q52590755 | A leukocyte activation test identifies food items which induce release of DNA by innate immune peripheral blood leucocytes. |
| Q47173109 | An algorithm for the classification of mRNA patters in eosinophilic esophagitis: integration of machine learning. |
| Q38962841 | Differences in eosinophil molecular profiles between children and adults with eosinophilic esophagitis |
| Q49386905 | Elevated expression of activated TH2 cells and milk-specific TH2 cells in milk-induced eosinophilic esophagitis. |
| Q49382776 | Eosinophilic Esophagitis Clinical Manifestations and Differential Diagnosis |
| Q64901085 | Eosinophilic Esophagitis in Children: Endoscopic Findings at Diagnosis and Post-intervention. |
| Q26741559 | Eosinophilic esophagitis: published evidences for disease subtypes, indications for patient subpopulations, and how to translate patient observations to murine experimental models |
| Q40422232 | Eosinophils from eosinophilic oesophagitis patients have T cell suppressive capacity and express FOXP3. |
| Q52671143 | Food allergen triggers are increased in children with the TSLP risk allele and eosinophilic esophagitis. |
| Q37442005 | Food allergy: immune mechanisms, diagnosis and immunotherapy |
| Q64241109 | Genetic, Inflammatory, and Epithelial Cell Differentiation Factors Control Expression of Human Calpain-14 |
| Q39183321 | Imaging of the oesophagus: beyond cancer |
| Q58592216 | Immunology of the Ancestral Differences in Eosinophilic Esophagitis |
| Q38849411 | Indications for gastrointestinal endoscopy in childhood |
| Q38834168 | New insights into basophil heterogeneity |
| Q47273589 | Noncanonical NF-κB signaling and the essential kinase NIK modulate crucial features associated with eosinophilic esophagitis pathogenesis |
| Q89866917 | Pathophysiology of Eosinophilic Esophagitis |
| Q38837172 | Pharmacological treatment of eosinophilic gastrointestinal disorders |
| Q44907389 | Risks for comorbidity in children with atopic disorders: an observational study in Dutch general practices |
| Q38719009 | Systematic review with network meta-analysis: comparative effectiveness of topical steroids vs. PPIs for the treatment of the spectrum of eosinophilic oesophagitis |
| Q30244169 | Temporal Regulation by Innate Type 2 Cytokines in Food Allergies |
| Q38613170 | Tissue Remodeling in Chronic Eosinophilic Esophageal Inflammation: Parallels in Asthma and Therapeutic Perspectives |
Search more.